First Time Loading...

Transgene SA
PAR:TNG

Watchlist Manager
Transgene SA Logo
Transgene SA
PAR:TNG
Watchlist
Price: 1.382 EUR -5.08% Market Closed
Updated: Apr 20, 2024

Wall Street
Price Targets

TNG Price Targets Summary
Transgene SA

Wall Street analysts forecast TNG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNG is 4.539 EUR with a low forecast of 3.535 EUR and a high forecast of 5.67 EUR.

Lowest
Price Target
3.535 EUR
156% Upside
Average
Price Target
4.539 EUR
228% Upside
Highest
Price Target
5.67 EUR
310% Upside
Transgene SA Competitors:
Price Targets
PSTX
Poseida Therapeutics Inc
607% Upside
BNTX
BioNTech SE
40% Upside
PRAX
Praxis Precision Medicines Inc
201% Upside
SPRY
ARS Pharmaceuticals Inc
129% Upside
BIO
Biotest AG
19% Downside
NBIX
Neurocrine Biosciences Inc
17% Upside
HZNP
Horizon Therapeutics PLC
0% Upside
ALVO
Alvotech SA
27% Upside

Revenue
Forecast

Revenue Estimate
Transgene SA

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 3 years is 58%.

-3%
Past Growth
58%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNG's stock price target?
Price Target
4.539 EUR

According to Wall Street analysts, the average 1-year price target for TNG is 4.539 EUR with a low forecast of 3.535 EUR and a high forecast of 5.67 EUR.

What is Transgene SA's Revenue forecast?
Projected CAGR
58%

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 3 years is 58%.